Published in J Biomed Res on September 01, 2011
Arginase 1 is an innate lymphoid-cell-intrinsic metabolic checkpoint controlling type 2 inflammation. Nat Immunol (2016) 1.50
Macrophage polarization drives granuloma outcome during Mycobacterium tuberculosis infection. Infect Immun (2014) 0.96
Increased mitochondrial arginine metabolism supports bioenergetics in asthma. J Clin Invest (2016) 0.81
Emerging concepts in smooth muscle contributions to airway structure and function: implications for health and disease. Am J Physiol Lung Cell Mol Physiol (2016) 0.75
Nitric Oxide Synthase Activity Correlates with OGG1 in Ozone-Induced Lung Injury Animal Models. Front Physiol (2017) 0.75
Arginine metabolic endotypes related to asthma severity. PLoS One (2017) 0.75
ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med (2005) 11.34
Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A (1991) 8.04
Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell (1995) 7.13
Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest (1995) 5.09
NO at work. Cell (1994) 5.07
Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest (2003) 4.08
Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci U S A (1996) 3.29
S-nitrosothiols signal the ventilatory response to hypoxia. Nature (2001) 3.26
Nitric oxide in health and disease of the respiratory system. Physiol Rev (2004) 3.15
Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation (2003) 3.01
Superoxide generation from endothelial nitric-oxide synthase. A Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J Biol Chem (1998) 2.92
Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration. Circ Res (2007) 2.91
Accelerated reaction of nitric oxide with O2 within the hydrophobic interior of biological membranes. Proc Natl Acad Sci U S A (1998) 2.56
Biological methylation: selected aspects. Annu Rev Biochem (1975) 2.53
Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells. Am J Physiol Endocrinol Metab (2001) 2.50
Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci U S A (1997) 2.47
The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. Am J Respir Crit Care Med (2007) 2.44
A GABAergic system in airway epithelium is essential for mucus overproduction in asthma. Nat Med (2007) 2.43
Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc Natl Acad Sci U S A (1994) 2.41
Recent advances in arginine metabolism: roles and regulation of the arginases. Br J Pharmacol (2009) 2.24
L-NG-nitro arginine inhibits non-adrenergic, non-cholinergic relaxations of guinea-pig isolated tracheal smooth muscle. Br J Pharmacol (1990) 2.12
Decreased arginine bioavailability and increased serum arginase activity in asthma. Am J Respir Crit Care Med (2004) 2.01
Inducible nitric-oxide synthase generates superoxide from the reductase domain. J Biol Chem (1998) 2.00
A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the "arginine paradox". J Biol Chem (1997) 1.97
The measurement of reticular basement membrane and submucosal collagen in the asthmatic airway. Clin Exp Allergy (1997) 1.87
S-nitrosothiol signaling in respiratory biology. Am J Respir Crit Care Med (2006) 1.84
Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor kappaB-binding sites. J Biol Chem (1998) 1.81
The inhibition of arginase by N(omega)-hydroxy-l-arginine controls the growth of Leishmania inside macrophages. J Exp Med (2001) 1.80
Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells. Am J Physiol Lung Cell Mol Physiol (2004) 1.79
Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats. J Appl Physiol (1985) (2009) 1.76
L-arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle. Circulation (1997) 1.75
Impairment of bronchoprotection by nitric oxide in severe asthma. Lancet (1997) 1.68
Nitrite potently inhibits hypoxic and inflammatory pulmonary arterial hypertension and smooth muscle proliferation via xanthine oxidoreductase-dependent nitric oxide generation. Circulation (2009) 1.58
The functional nitrite reductase activity of the heme-globins. Blood (2008) 1.58
Muscle and plasma amino acids following injury. Influence of intercurrent infection. Ann Surg (1980) 1.55
Probing erectile function: S-(2-boronoethyl)-L-cysteine binds to arginase as a transition state analogue and enhances smooth muscle relaxation in human penile corpus cavernosum. Biochemistry (2001) 1.51
Arginase I induction in macrophages, triggered by Th2-type cytokines, supports the growth of intracellular Leishmania parasites. Parasite Immunol (2002) 1.44
Inhibition of arginase I activity by RNA interference attenuates IL-13-induced airways hyperresponsiveness. J Immunol (2006) 1.40
Substrate supply for nitric-oxide synthase in macrophages and endothelial cells: role of cationic amino acid transporters. Mol Pharmacol (2000) 1.39
Design of amino acid sulfonamides as transition-state analogue inhibitors of arginase. J Am Chem Soc (2003) 1.37
Functionally important role for arginase 1 in the airway hyperresponsiveness of asthma. Am J Physiol Lung Cell Mol Physiol (2009) 1.37
Arginase II downregulates nitric oxide (NO) production and prevents NO-mediated apoptosis in murine macrophage-derived RAW 264.7 cells. J Cell Biol (1999) 1.35
Overexpression of arginase in the aged mouse penis impairs erectile function and decreases eNOS activity: influence of in vivo gene therapy of anti-arginase. Am J Physiol Heart Circ Physiol (2006) 1.34
Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: characterization of differences between human and mouse iNOS promoters. Biochem Biophys Res Commun (1998) 1.29
Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis. Br J Pharmacol (1994) 1.28
Arginase inhibition protects against allergen-induced airway obstruction, hyperresponsiveness, and inflammation. Am J Respir Crit Care Med (2008) 1.25
Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochem J (1996) 1.24
Arginase: marker, effector, or candidate gene for asthma? J Clin Invest (2003) 1.24
Airway smooth muscle growth in asthma: proliferation, hypertrophy, and migration. Proc Am Thorac Soc (2008) 1.23
Regulation of ciliary beat frequency by the nitric oxide-cyclic guanosine monophosphate signaling pathway in rat airway epithelial cells. Am J Respir Cell Mol Biol (2000) 1.23
Selective inducible nitric oxide synthase inhibition has no effect on allergen challenge in asthma. Am J Respir Crit Care Med (2007) 1.22
Arginine, citrulline and nitric oxide metabolism in sepsis. Clin Sci (Lond) (2009) 1.21
Mitochondrial arginase II constrains endothelial NOS-3 activity. Am J Physiol Heart Circ Physiol (2007) 1.21
Arginine in asthma and lung inflammation. J Nutr (2004) 1.19
Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat. J Hypertens (2008) 1.18
Arginase and pulmonary diseases. Naunyn Schmiedebergs Arch Pharmacol (2008) 1.16
Deficiency of nitric oxide in allergen-induced airway hyperreactivity to contractile agonists after the early asthmatic reaction: an ex vivo study. Br J Pharmacol (1996) 1.16
Mitochondrial arginase II modulates nitric-oxide synthesis through nonfreely exchangeable L-arginine pools in human endothelial cells. J Pharmacol Exp Ther (2006) 1.14
A comprehensive evaluation of the enzymatic and nonenzymatic antioxidant systems in childhood asthma. J Allergy Clin Immunol (2008) 1.14
Inhibition of arginase activity enhances inflammation in mice with allergic airway disease, in association with increases in protein S-nitrosylation and tyrosine nitration. J Immunol (2008) 1.13
Rat liver arginase: kinetic mechanism, alternate substrates, and inhibitors. Arch Biochem Biophys (1994) 1.13
Classical and slow-binding inhibitors of human type II arginase. Biochemistry (2001) 1.12
Increased levels of hypoxia-sensitive proteins in allergic airway inflammation. Am J Respir Crit Care Med (2004) 1.11
Beneficial effects of high dose of L-arginine on airway hyperresponsiveness and airway inflammation in a murine model of asthma. J Allergy Clin Immunol (2010) 1.08
Overexpression of endothelial nitric oxide synthase suppresses features of allergic asthma in mice. Respir Res (2006) 1.07
Structural specificity of substrate for S-adenosylmethionine:protein arginine N-methyltransferases. Biochim Biophys Acta (1995) 1.06
Polyamines: fundamental characters in chemistry and biology. Amino Acids (2009) 1.05
Asthma management: reinventing the wheel in sickle cell disease. Am J Hematol (2009) 1.03
Liver I/R injury is improved by the arginase inhibitor, N(omega)-hydroxy-nor-L-arginine (nor-NOHA). Am J Physiol Gastrointest Liver Physiol (2006) 1.03
Arginase blockade protects against hepatic damage in warm ischemia-reperfusion. Nitric Oxide (2008) 1.03
Arginases I and II in lungs of ovalbumin-sensitized mice exposed to ovalbumin: sources and consequences. Toxicol Appl Pharmacol (2008) 1.02
Arginase strongly impairs neuronal nitric oxide-mediated airway smooth muscle relaxation in allergic asthma. Respir Res (2006) 1.02
Direct inhibition of arginase attenuated airway allergic reactions and inflammation in a Dermatophagoides farinae-induced NC/Nga mouse model. Am J Physiol Lung Cell Mol Physiol (2010) 1.02
Dual action of nitric oxide on airway plasma leakage. Am J Respir Crit Care Med (1997) 1.00
Role of L-arginine in the deficiency of nitric oxide and airway hyperreactivity after the allergen-induced early asthmatic reaction in guinea-pigs. Br J Pharmacol (1999) 1.00
Arginase enzymes in isolated airways from normal and nitric oxide synthase 2-knockout mice exposed to ovalbumin. Toxicol Appl Pharmacol (2008) 0.99
Glucocorticoids inhibit lipopolysaccharide-induced up-regulation of arginase in rat alveolar macrophages. Br J Pharmacol (2001) 0.99
Simvastatin inhibits goblet cell hyperplasia and lung arginase in a mouse model of allergic asthma: a novel treatment for airway remodeling? Transl Res (2010) 0.99
Identification of a classic cytokine-induced enhancer upstream in the human iNOS promoter. FASEB J (2006) 0.98
Increased arginase activity contributes to airway remodelling in chronic allergic asthma. Eur Respir J (2011) 0.96
Modulation of cholinergic airway reactivity and nitric oxide production by endogenous arginase activity. Br J Pharmacol (2000) 0.96
Transiently, paralleled upregulation of arginase and nitric oxide synthase and the effect of both enzymes on the pathology of asthma. Am J Physiol Lung Cell Mol Physiol (2007) 0.94
Diclofenac inhibits tumor growth in a murine model of pancreatic cancer by modulation of VEGF levels and arginase activity. PLoS One (2010) 0.94
eNOS phosphorylation: a pivotal molecular switch in vasodilation and cardioprotection? J Mol Cell Cardiol (2006) 0.94
2-aminoimidazole amino acids as inhibitors of the binuclear manganese metalloenzyme human arginase I. J Med Chem (2010) 0.93
Arginase inhibition in airways from normal and nitric oxide synthase 2-knockout mice exposed to ovalbumin. Toxicol Appl Pharmacol (2009) 0.93
Arginase attenuates inhibitory nonadrenergic noncholinergic nerve-induced nitric oxide generation and airway smooth muscle relaxation. Respir Res (2005) 0.93
Accessibility of endothelial and inducible nitric oxide synthase to the intracellular citrulline-arginine regeneration pathway. Biochem Pharmacol (2005) 0.92
Strain-dependent activation of NF-kappaB in the airway epithelium and its role in allergic airway inflammation. Am J Physiol Lung Cell Mol Physiol (2009) 0.92
Human arginase isozymes. Isozymes Curr Top Biol Med Res (1987) 0.92
L-arginine reduces endothelial inflammation and myocardial stunning during ischemia/reperfusion. Ann Thorac Surg (1995) 0.91
Coupled and uncoupled NOS: separate but equal? Uncoupled NOS in endothelial cells is a critical pathway for intracellular signaling. Circ Res (2006) 0.91
Structural aspects of airway remodeling in asthma. Curr Allergy Asthma Rep (2008) 0.90
Arginine, citrulline, and nitric oxide metabolism in end-stage renal disease patients. J Clin Invest (2000) 0.90
Characterization of L-arginine transport by pulmonary artery endothelial cells. Am J Physiol (1993) 0.90
Creatine supplementation exacerbates allergic lung inflammation and airway remodeling in mice. Am J Respir Cell Mol Biol (2007) 0.89
Glucocorticoid inhibition of interleukin-4 (IL-4) and interleukin-13 (IL-13) induced up-regulation of arginase in rat airway fibroblasts. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.88
Bone marrow cell derived arginase I is the major source of allergen-induced lung arginase but is not required for airway hyperresponsiveness, remodeling and lung inflammatory responses in mice. BMC Immunol (2009) 0.88
Pharmacokinetics of arginine and related amino acids. J Nutr (2007) 0.86
Mouse models of asthma: can they give us mechanistic insights into the role of nitric oxide? Curr Med Chem (2007) 0.85
Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy. Eur Respir J (2012) 2.06
Preliminary evaluation of DNA damage related with the smoking habit measured by the comet assay in whole blood cells. Cancer Epidemiol Biomarkers Prev (2004) 1.49
Simvastatin inhibits airway hyperreactivity: implications for the mevalonate pathway and beyond. Am J Respir Crit Care Med (2009) 1.38
The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations. Expert Rev Clin Pharmacol (2013) 1.36
Vitamin A deficiency decreases and high dietary vitamin A increases disease severity in the mouse model of asthma. J Immunol (2008) 1.28
California wildfires of 2008: coarse and fine particulate matter toxicity. Environ Health Perspect (2009) 1.12
Susceptibility to ozone-induced acute lung injury in iNOS-deficient mice. Am J Physiol Lung Cell Mol Physiol (2002) 1.09
Airway fibrosis in a mouse model of airway inflammation. Toxicol Appl Pharmacol (2003) 1.09
Analyte peptidomimetics selected from phage display peptide libraries: a systematic strategy for the development of environmental immunoassays. Environ Sci Technol (2005) 1.07
ELISA as an affordable methodology for monitoring groundwater contamination by pesticides in low-income countries. Environ Sci Technol (2005) 1.03
Arginases I and II in lungs of ovalbumin-sensitized mice exposed to ovalbumin: sources and consequences. Toxicol Appl Pharmacol (2008) 1.02
PPARγ agonist rosiglitazone prevents perinatal nicotine exposure-induced asthma in rat offspring. Am J Physiol Lung Cell Mol Physiol (2011) 1.00
Arginase enzymes in isolated airways from normal and nitric oxide synthase 2-knockout mice exposed to ovalbumin. Toxicol Appl Pharmacol (2008) 0.99
Simvastatin inhibits goblet cell hyperplasia and lung arginase in a mouse model of allergic asthma: a novel treatment for airway remodeling? Transl Res (2010) 0.99
Competitive selection from single domain antibody libraries allows isolation of high-affinity antihapten antibodies that are not favored in the llama immune response. Anal Chem (2011) 0.98
Lung response to coarse PM: bioassay in mice. Toxicol Appl Pharmacol (2008) 0.97
Lung antioxidant and cytokine responses to coarse and fine particulate matter from the great California wildfires of 2008. Inhal Toxicol (2010) 0.97
Differential effects of simvastatin on IL-13-induced cytokine gene expression in primary mouse tracheal epithelial cells. Respir Res (2012) 0.97
Statin drugs, metabolic pathways, and asthma: a therapeutic opportunity needing further research. Drug Metab Lett (2011) 0.97
Robust and sensitive monoclonal enzyme-linked immunosorbent assay for the herbicide molinate. J Agric Food Chem (2004) 0.96
Systemic responses to inhaled ozone in mice: cachexia and down-regulation of liver xenobiotic metabolizing genes. Toxicol Appl Pharmacol (2005) 0.95
Arginase inhibition in airways from normal and nitric oxide synthase 2-knockout mice exposed to ovalbumin. Toxicol Appl Pharmacol (2009) 0.93
A clomazone immunoassay to study the environmental fate of the herbicide in rice (Oryza sativa) agriculture. J Agric Food Chem (2010) 0.92
Susceptibility to ovalbumin-induced airway inflammation and fibrosis in inducible nitric oxide synthetase-deficient mice: mechanisms and consequences. Toxicol Appl Pharmacol (2003) 0.91
A monoclonal antibody-based copro-ELISA kit for canine echinococcosis to support the PAHO effort for hydatid disease control in South America. PLoS Negl Trop Dis (2013) 0.89
Dietary long-chain omega-3 fatty acids do not diminish eosinophilic pulmonary inflammation in mice. Am J Respir Cell Mol Biol (2014) 0.89
Non-enzymatic glycation of type I collagen diminishes collagen-proteoglycan binding and weakens cell adhesion. J Cell Biochem (2008) 0.88
Ovalbumin-induced airway inflammation and fibrosis in mice also exposed to ultrafine particles. Inhal Toxicol (2004) 0.86
Chemically Polymerized Polypyrrole for On-Chip Concentration of Volatile Breath Metabolites. Sens Actuators B Chem (2010) 0.86
Ozone-induced disruptions of lung transcriptomes. Biochem Biophys Res Commun (2003) 0.86
The critically ill asthmatic--from ICU to discharge. Clin Rev Allergy Immunol (2012) 0.85
Soluble epoxide hydrolase inhibitor attenuates inflammation and airway hyperresponsiveness in mice. Am J Respir Cell Mol Biol (2015) 0.85
Cell-specific oxidative stress and cytotoxicity after wildfire coarse particulate matter instillation into mouse lung. Toxicol Appl Pharmacol (2012) 0.84
Severe vitamin E deficiency modulates airway allergic inflammatory responses in the murine asthma model. Free Radic Res (2008) 0.84
Ovalbumin-induced airway inflammation and fibrosis in mice also exposed to ozone. Inhal Toxicol (2004) 0.83
Definition of critical asthma syndromes. Clin Rev Allergy Immunol (2015) 0.82
Tracking retention and transport of ultrafine polystyrene in an asthmatic mouse model using positron emission tomography. Exp Lung Res (2013) 0.82
Mouse lung inflammation after instillation of particulate matter collected from a working dairy barn. Toxicol Appl Pharmacol (2009) 0.82
Continuous droplet removal upon dropwise condensation of humid air on a hydrophobic micropatterned surface. Langmuir (2014) 0.82
Nitric oxide synthase enzymes in the airways of mice exposed to ovalbumin: NOS2 expression is NOS3 dependent. Mediators Inflamm (2010) 0.81
A mobile instrumentation platform to distinguish airway disorders. J Breath Res (2013) 0.81
Why is particulate matter produced by wildfires toxic to lung macrophages? Toxicol Appl Pharmacol (2011) 0.81
Differentiation of the roles of NO from airway epithelium and inflammatory cells in ozone-induced lung inflammation. Toxicol Appl Pharmacol (2006) 0.81
Design-of-experiment optimization of exhaled breath condensate analysis using a miniature differential mobility spectrometer (DMS). Anal Chim Acta (2008) 0.81
Statin use and asthma control in patients with severe asthma. BMJ Open (2013) 0.81
ITREOH building of regional capacity to monitor recreational water: development of a non-commercial microcystin ELISA and its impact on public health policy. Int J Occup Environ Health (2006) 0.80
Temperature changes in exhaled breath condensate collection devices affect observed acetone concentrations. J Breath Res (2008) 0.80
Bench-to-bedside review: the role of nitric oxide in sepsis. Expert Rev Respir Med (2009) 0.80
Geoepidemiology of COPD and idiopathic pulmonary fibrosis. J Autoimmun (2009) 0.80
Enzyme-linked immunosorbent assay for screening dioxin soil contamination by uncontrolled combustion during informal recycling in slums. Environ Toxicol Chem (2008) 0.80
Endogenous Levels of Five Fatty Acid Metabolites in Exhaled Breath Condensate to Monitor Asthma by High-Performance Liquid Chromatography: Electrospray Tandem Mass Spectrometry. IEEE Sens J (2010) 0.80
The pharmacological approach to the elderly COPD patient. Drugs Aging (2013) 0.79
A fresh look at paralytics in the critically ill: real promise and real concern. Ann Intensive Care (2012) 0.78
Limited analytical capacity for cyanotoxins in developing countries may hide serious environmental health problems: simple and affordable methods may be the answer. J Environ Manage (2012) 0.78
Difficult-to-control asthma in adults. Am J Med (2007) 0.78
Specific immunoassays for endocrine disruptor monitoring using recombinant antigens cloned by degenerated primer PCR. Anal Bioanal Chem (2007) 0.78
Human breath metabolomics using an optimized non-invasive exhaled breath condensate sampler. J Breath Res (2016) 0.76
Automatic lung segmentation using control feedback system: morphology and texture paradigm. J Med Syst (2015) 0.76
Self-assembling nanoparticles containing dexamethasone as a novel therapy in allergic airways inflammation. PLoS One (2013) 0.76
The adult asthmatic. Clin Rev Allergy Immunol (2012) 0.76
Increasing capacity for environmental engineering in Salta, Argentina. Am J Ind Med (2012) 0.75
Immunobiology of the critical asthma syndrome. Clin Rev Allergy Immunol (2015) 0.75
Absence of respiratory inflammatory reaction of elemental sulfur using the California Pesticide Illness Database and a mouse model. J Agromedicine (2005) 0.75
Autophagy and the Unfolded Protein Response Promote Pro-fibrotic Effects of TGFβ1 in Human Lung Fibroblasts. Am J Physiol Lung Cell Mol Physiol (2017) 0.75
Emerging topics and new developments in the field: the 2012 International Breath Analysis meeting. J Breath Res (2013) 0.75
A 40-year-old woman with cough and dyspnea 2 months after a motorcycle accident. Chest (2013) 0.75